PPARG and Miyoshi myopathy: This report showed that growthinhibition and certain downstream signaling events were PPARγ-dependent, and alsothat two IL-6-dependent MM lines expressed PPARγ while an IL-6-independent line did not [31].Also, GW9662 was reported to block the effects of the agonists, and had no antiproliferative activity on its own.